F
P. Kumari et al.
Letter
Synlett
Supporting Information
(14) Sharma, N.; Chundawat, T. S.; Mohapatra, S. C.; Bhagat, S. Syn-
thesis 2016, 48, 4495.
(15) Sharma, N.; Chundawat, T. S.; Mohapatra, S. C.; Bhagat, S. RSC
Adv. 2013, 3, 16336.
Supporting information for this article is available online at
S
u
p
p
ortiInfogrmoaitn
S
u
p
p
ortioInfgrmoaitn
(16) Sharma, N.; Kumari, N.; Chundawat, T. S.; Bhagat, S. RSC Adv.
2017, 7, 10150.
(17) Yang, C. W.; Bai, Y. X.; Zhang, N. T.; Zeng, C. C.; Hua, L. M.; Tian,
H. Y. Tetrahedron 2012, 68, 10201.
References and Notes
(1) (a) Gouverneur, V.; Muller, K. Fluorine in Pharmaceutical and
Medicinal Chemistry: From Biophysical Aspects to Clinical Appli-
cations; Imperial College Press: London, 2012. (b) Begue, J.-P. D.
Biorganic and Medicinal Chemistry of Fluorine; Wiley-VCH:
Hoboken, 2008. (c) Ojima, I. Fluorine in Medicinal Chemistry and
Chemical Biology; Wiley: Blackwell, Chichester, 2009.
(2) (a) Ladner, Y.; D’Orly, F.; Perre, C.; Silva, B.-D.; Guyon, C.;
Tatoulian, M. Plasma Process. Polym. 2014, 11, 518. (b) Kimura,
T.; Kasuya, M. C.; Hatanaka, K.; Matsuoka, K. Molecules 2016, 21,
358. (c) Narita, T. Polymer J. 2011, 43, 497.
(3) (a) Theodoridis, G. Adv. fluorine Sci. 2006, 2, 121. (b) Ritter, S. K.
Chem. Eng. News 2012, 90, 10. (c) Shimizu, M.; Hiyama, T.
Angew. Chem. Int. Ed. 2005, 44, 214.
(4) (a) Franz, J.-E.; Kaufman, R.-J. PCT Int. Appl WO 4180394, 1979.
(b) Franz, J.-E.; Kaufman, R.-J. PCT Int. Appl WO 4195983, 1980.
(5) Zhou, S.; Gu, Y.; Liu, M.; Wu, C.; Zhou, S.; Zhao, Y.; Jia, Z.; Wang,
B.; Xiong, L.; Yang, N.; Li, Z. J. Agric. Food Chem. 2014, 62, 11054.
(6) Ohno, I.; Tomizawa, M.; Aoshima, A.; Kumazawa, S.; Kagabu, S.
J. Agric. Food Chem. 2010, 58, 4999.
(7) (a) Kamitori, Y.; Hojo, M.; Masuda, R.; Fujitani, T.; Kobuchi, T.;
Nishigaki, T. Synthesis 1986, 340. (b) Hojo, M.; Masuda, R.;
Okada, E.; Mochizuki, Y. Synthesis 1992, 455. (c) Moriguchi, T.;
Endo, T. J. Org. Chem. 1995, 60, 3523.
(8) Roper, W. L. Toxicological Profile for Pyridine; Toxic Substances
and Disease Registry: US Public Health Service, 1992, 52.
(9) (a) Nikseresht, A.; Bakavoli, M.; Bayraq, S. S. Synth. Commun.
2014, 44, 2662. (b) Kumari, S.; Singh, H.; Khurana, J. M. Tetrahe-
dron Lett. 2016, 57, 3081. (c) Rajeswari, M.; Saluja, P.; Khurana,
J. M. RSC Adv. 2016, 6, 1307.
(10) (a) Dieter, R. K. Tetrahedron 1986, 42, 3029. (b) Junjappa, H.; Ila,
H.; Asokan, C. V. Tetrahedron 1990, 46, 5423. (c) Kolb, M.; Bi, X.;
Liu, Q. Chem. Soc. Rev. 2013, 42, 1251. (d) Pan, L.; Liu, Q. Synlett
2011, 1073. (e) Liu, Q.; Nielsen, M. B.; Krause, N.; Marek, I.;
Schaumann, E.; Wirth, T. Science of Synthesis Knowledge Updates
2014/2; Georg Thieme: Stuttgart, Germany, 2014, section
24.2.11.3, 245. (f) Wang, L.; He, W.; Yu, Z. Chem. Soc. Rev. 2013,
42, 599.
(18) General Procedure for the Synthesis of Trifluoroacetylated
Enaminones 3a–s: To a solution of enaminones 2a–s (1 equiv)
in DCE (5 mL) was added DBU (2 equiv) under a N2 atmosphere.
TFAA (2.5 equiv) was added dropwise over 10 min, keeping the
temperature at 0 °C. When addition was complete, the mixture
was allowed to warm slowly to r.t. and stirred for 2 h, monitor-
ing by TLC. After completion of the reaction, the mixture was
quenched with aq NaHCO3, then washed with dilute HCl and
finally H2O. The mixture was extracted with CH2Cl2 and the
organic layer was dried over anhyd Na2SO4. After filtering and
concentrating by rotary evaporation,
a solid product was
obtained that was crystallized from Et2O–pentane (5%) to give
the pure compounds 3a–s.
(E)-1-(4-Chlorophenyl)-2-[(cyclohexylamino)(meth-
ylthio)methylene]-4,4,4-trifluorobutane-1,3-dione (3l): The
compound was obtained as a white solid; mp 108–110 °C;
yield: 0.36 g (94%). IR (KBr): 3448, 2933, 1726, 1654, 1574, 1460
cm–1. 1H NMR (400 MHz, CDCl3): δ = 12.07 (br s, 1 H, NH), 7.75
(t, J = 8.4 Hz, 2 H), 7.35 (d, J = 8.4 Hz, 2 H), 3.95 (s, 1 H, NHCH),
2.19 (s, 3 H, SMe), 1.87–1.90 (m, 3 H), 1.72–1.74 (m, 2 H), 1.55–
1.57 (m, 1 H), 1.24–1.46 (m, 4 H). 13C NMR (100 MHz, CDCl3):
δ = 191.17, 174.01 (COCF3), 167.94, 139.44, 137.82, 130.57,
128.83, 128.64, 128.44, 118.75, 115.88 (COCF3), 107.74
(=CCOCF3), 55.21, 33.36, 24.95, 24.16, 19.43 (SMe). 19F NMR
(376 MHz, CDCl3): δ = –70.68 (s, 3 F, COCF3). HRMS (ESI): m/z [M
+ H]+ calcd for C18H19ClF3NO2S: 406.0855; found: 406.0853.
(E)-4,4,4-Trifluoro-2-1-(4-chlorophenyl)-2[(meth-
ylthio)(propylamino)methylene]-1-[3-(trifluoromethyl)phe-
nyl]butane-1,3-dione (3q): The compound was obtained as a
white solid; mp 60–62 °C; yield: 0.37 g (95%). IR (KBr): 3418,
2903, 1723, 1621, 1562, 1464 cm–1. 1H NMR (400 MHz, CDCl3):
δ = 11.95 (br s, 1 H, NH), 8.06 (s, 1 H), 7.99 (d, J = 7.6 Hz, 1 H),
7.74 (d, J = 7.6 Hz, 1 H), 7.54 (d J = 7.6 Hz, 1 H), 3.58 (q, J = 6.1 Hz,
2 H), 2.15 (s, 3 H, SMe), 1.65–1.74 (m, 2 H), 1.00 (t, 3 H). 13C
NMR (100 MHz, CDCl3): δ = 190.76, 174.42 (COCF3), 169.21,
140.03, 132.26, 129.21, 128.08, 125.77, 115.78 (COCF3), 107.67
(=CCOCF3), 48.06, 23.14, 18.48 (SMe), 11.29 (Me). 19F NMR (376
MHz, CDCl3): δ = –63.73 (s, 3 F, ArCF3), –71.87 (s, 3 F, COCF3).
HRMS (ESI): m/z [M + H]+ calcd for C16H15F6NO2S: 400.0806;
found: 400.0801.
(11) Zhang, L.; Dong, J.; Xu, J.; Liu, Q. Chem. Rev. 2016, 116, 287.
(12) Hojo, M.; Masuda, R.; Okada, E.; Yamamoto, H.; Morimoto, K.;
Okada, K. Synthesis 1990, 195.
(13) Barabanov, M. A.; Sevenard, D. V.; Sosnovskikh, V. Y. Russ. Chem.
Bull., Int. Ed. 2012, 61, 1646.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2017, 28, A–F